Continuous renal replacement therapy is a specialized blood purification therapy that provides slow, continuous removal of waste products and fluid overload over 24 hours, maintaining hemodynamic stability in critically ill patients with acute kidney injury. Continuous renal replacement therapy is essential for critical care, providing the continuous blood purification that supports patient survival and recovery. The Hemofiltration Machine Market is expected to grow from 846.3 USD Million in 2025 to 1,500 USD Million by 2035. These hemofiltration machines are the primary CRRT delivery systems. Blood filtration systems provide the purification mechanism. Critical care dialysis equipment includes CRRT machines.

The global CRRT market is characterized by increasing demand for continuous blood purification solutions that support critical care outcomes and patient survival. By modality, the market includes Continuous Veno-Venous Hemofiltration and Continuous Veno-Venous Hemodiafiltration. CVVH is the largest segment, offering efficient convective clearance. By setting, the market includes ICU and Non-ICU settings. ICU is the largest setting, where CRRT is most commonly used. The global market for Continuous Veno-Venous Hemofiltration Equipment was valued at US1200millionin2024andisprojectedtoreachUS1200millionin2024andisprojectedtoreachUS 1684 million by 2031. The increasing incidence of acute kidney injury in critically ill patients is driving the CRRT market. The future of continuous renal replacement therapy lies in continued innovation in therapy delivery, anticoagulation management, and integration with critical care monitoring that enables more effective, safe, and patient-centered renal support.